ViaLase is redefining glaucoma treatment with 200+ years of combined experience creating femtosecond laser technology. Discover the new ViaLuxe Laser System.
Shawn O'Neil · Executive Officer · decision-maker
Hadi Srass · Executive Officer · decision-maker
Rick Lewis · Executive Officer · decision-maker
Scott Cooper · Executive Officer · decision-maker
Careers mailbox is known
Jul 30, 2024
Certified ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase Laser · vialase.com
Mar 25, 2024
Raised a round Venture round $45.2M · SEC Form D
Nov 15, 2022
New executive ViaLase Strengthens Executive Team with the Appointments of Tom Frinzi as Executive Chairman of the Board, Richard Lewis, M.D., as Chief Medical Offi… · PRNewswire
2019
Founded
SonarMD uses advanced digital tools to proactively detect deteriorating gut health — so IBD patients receive the right care at the right time, resulting in.
Beth Houck · Executive Officer, Director · decision-maker
Devin Gross · Executive Officer, Director · decision-maker
Lawrence Kosinski · Director · decision-maker
John Starr · Executive Officer · decision-maker
Careers mailbox is known
Feb 18
Raised a round Venture round $3M · SEC Form D
Oct 20, 2024
Partnership SonarMD Partners with LyfeMD and Movement Genius to Expand Holistic Health Support for Inflammatory Bowel Disease (IBD) Patients · sonarmd.com
Reprieve Cardiovascular is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.
No named decision-maker yet.
Careers mailbox is known
The majority of molecules sequenced are uninformative. Jumpcode Genomics is changing that by helping researchers boost usable NGS data.
David Salter · Executive Officer, Director · decision-maker
Brandon Poe · Executive Officer · decision-maker
Yaron Hakak · Executive Officer, Director · decision-maker
Keith Brown · Executive Officer · decision-maker
No careers mailbox known
Aug 15, 2024
Raised a round Venture round $3.5M · SEC Form D
2016
Founded
Francis Medical is a medical device company that develops innovative, minimally invasive therapies for prostate, kidney, & bladder conditions.
Michael Kujak · Executive Officer, Director · decision-maker
Michael Hoey · Director · decision-maker
Andrew Cleeland · Director
Jan Garfinkle · Director
Careers mailbox is known
2025
Team of 60 was 40 · US Form 5500 (plan participants)
Dec 2, 2025
Certified Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish Water Vapor System for Prostate Tissue Ablation · francismedical.com
Dec 16, 2024
Raised a round Venture round $40M · SEC Form D
2018
Founded
At Enumera Molecular we are transforming the field of complex diagnostic testing to a simpler, cost-effective tool for physicians to benefit patient care.
Matthew Cooper · Executive Officer, Director · decision-maker
Careers mailbox is known
2025
Team shrank to 13 was 24 · US Form 5500 (plan participants)
May 4, 2022
Raised a round Venture round $18.7M · SEC Form D
2022
Founded
Novel treatment solutions to address Type 2 Diabetes for patients, providers and healthcare systems around the world. In partnership with Mayo Clinic.
Robert Kukujlan · Executive Officer · decision-maker
Michael Brenzel · Executive Officer · decision-maker
Robert Kukuljan · Executive Officer · decision-maker
Paul Hindrichs · Executive Officer, Director · decision-maker
Careers mailbox is known
Jan 14, 2025
New executive Endogenex Appoints Krissy Wright as Chief Financial Officer · PRNewswire
Jun 13, 2024
Raised a round Venture round $69.6M · SEC Form D
2017
Founded
BrightSpec commercializes MRR spectroscopy instruments for definitive molecular structure identification and quantitation.
Walter Colsman · Executive Officer, Director · decision-maker
David Mcdaniel · Executive Officer, Director · decision-maker
Robert Lloyd · Executive Officer, Director · decision-maker
Timothy Germann · Director
Careers mailbox is known
Oct 6, 2025
New executive BrightSpec Names Rick Gordon as CEO · YahooFinance
Apr 22, 2025
Raised a round Venture round $3.9M · SEC Form D
2012
Founded
The Expertise To Deliver Results The Expertise To Deliver Results The Hicuity Health journey began in the intensive care unit, where we innovated an independent tele-ICU solution to make intensivist-led care accessible for any hospital or health system.
No named decision-maker yet.
Careers mailbox is known
Sep 26
Posted 4 roles Telemetry Technician/Cardiac Monitoring Tech, EKG/Telemetry Technician/Cardiac Monitoring Tech
4 open
truth B 75 100% stale
RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid biopsy. Its Orion spatial proteomics platform enables single-round high-plex immunofluorescence imaging for translational and clinical research.
Stephen Reichenbach · Executive Officer · decision-maker
Joseph Victor Jr. · Executive Officer, Director · decision-maker
Jim Cooper · Executive Officer · decision-maker
Eric Kaldjian · Executive Officer · decision-maker
No careers mailbox known
Jul 12, 2023
Raised a round Venture round $13.2M · SEC Form D
Apr 15, 2018
Launched RareCyte introduces the CyteFinder HT instrument at AACR for high throughput slide-based imaging optimized for single cell Liquid Biopsy · medindia.net
2009
Founded
